Interferon-alfa for chronic myeloid leukemia
Authors:
- Michele BaccaraniMBMichele Baccarani
- Domenico RussoDRDomenico Russo
- Gianantonio RostiGRGianantonio Rosti
- Giovanni MartinelliGMGiovanni Martinelli
- 1 January 2003
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 40 (1) , 22-33
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- A randomized study of interferon-α versus interferon-α and low-dose arabinosyl cytosine in chronic myeloid leukemiaBlood, 2002
- Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic respondersBlood, 2001
- Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α–treated chronic myeloid leukemiaBlood, 2001
- ABL1 Methylation Is a Distinct Molecular Event Associated With Clonal Evolution of Chronic Myeloid LeukemiaBlood, 1999
- The Adverse Influence of Pretransplant Interferon- (IFN-) on Transplant Outcome After Marrow Transplantation for Chronic Phase Chronic Myelogenous Leukemia Increases With the Duration of IFN- ExposureBlood, 1999
- Randomized Study on Hydroxyurea Alone Versus Hydroxyurea Combined With Low-Dose Interferon-α2b for Chronic Myeloid LeukemiaBlood, 1998
- Molecular Follow-Up of Disease Progression and Interferon Therapy in Chronic Myelocytic LeukemiaBlood, 1997
- Granulocyte colony‐stimulating factor given in addition to interferon‐α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemiaBritish Journal of Haematology, 1997
- UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic responseThe Lancet, 1995
- Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation GroupBlood, 1993